Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatoshi Kikuchi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[Hepatic glucose metabolism and its regulation]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Structures and mechanisms for non SU insulin secretagogues]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Insulin release impairment in IGT]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Nateglinide]Yoko Notoya, Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Glycosuria]Motonobu Anai, Masatoshi Kikuchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|February 9, 2010
[Influence of plasma glucose variability and age on onset of diabetic retinopathy in diabetic patients analysis of results of long-term outpatient follow-up for 30 years or more]Toshiko Takao, Mineko Okayasu, Hiroyuki Yanagisawa, et al.
Journal of Diabetes and Its Complications|December 17, 2013
Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetesToshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, et al.
Journal of Diabetes and Its Complications|April 8, 2014
Association between HbA1c variability and mortality in patients with type 2 diabetesToshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, et al.
Current Medical Research and Opinion|May 17, 2012
Efficacy and tolerability of rosiglitazone and pioglitazone in drug-naïve Japanese patients with type 2 diabetes mellitus: a double-blind, 28 weeks' treatment, comparative studyMasatoshi Kikuchi, Kohei Kaku, Masato Odawara, et al.
Endocrine Journal|June 10, 2009
Effect of mitiglinide on glycemic control over 52 weeks in Japanese type 2 diabetic patients insufficiently controlled with pioglitazone monotherapyKohei Kaku, Shun-Ichi Tanaka, Hideki Origasa, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2002
[Hepatic glucose metabolism and its regulation]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Structures and mechanisms for non SU insulin secretagogues]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 23, 2005
[Insulin release impairment in IGT]Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Nateglinide]Yoko Notoya, Masatoshi Kikuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 3, 2002
[Glycosuria]Motonobu Anai, Masatoshi Kikuchi
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|February 9, 2010
[Influence of plasma glucose variability and age on onset of diabetic retinopathy in diabetic patients analysis of results of long-term outpatient follow-up for 30 years or more]Toshiko Takao, Mineko Okayasu, Hiroyuki Yanagisawa, et al.
Journal of Diabetes and Its Complications|December 17, 2013
Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetesToshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, et al.
Journal of Diabetes and Its Complications|April 8, 2014
Association between HbA1c variability and mortality in patients with type 2 diabetesToshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, et al.
Current Medical Research and Opinion|May 17, 2012
Efficacy and tolerability of rosiglitazone and pioglitazone in drug-naïve Japanese patients with type 2 diabetes mellitus: a double-blind, 28 weeks' treatment, comparative studyMasatoshi Kikuchi, Kohei Kaku, Masato Odawara, et al.
Endocrine Journal|June 10, 2009
Effect of mitiglinide on glycemic control over 52 weeks in Japanese type 2 diabetic patients insufficiently controlled with pioglitazone monotherapyKohei Kaku, Shun-Ichi Tanaka, Hideki Origasa, et al.
Pageof 4